Literature DB >> 18759286

The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population.

John M Davis1, Véronique L Roger, Cynthia S Crowson, Hilal Maradit Kremers, Terry M Therneau, Sherine E Gabriel.   

Abstract

OBJECTIVE: To compare the clinical presentation, management, and outcome of heart failure in patients with rheumatoid arthritis (RA) compared with non-RA patients.
METHODS: We conducted a community-based cohort study in the setting of Olmsted County, Minnesota, from 1979 to 2000. One hundred three patients with RA and 852 non-RA patients with incident heart failure (physician diagnosed and Framingham criteria validated) were compared. Age- and sex-adjusted rates/frequencies and multivariable logistic regression models were used to compare the clinical features and mortality of heart failure following its onset in the 2 groups of patients.
RESULTS: The patients with RA were more often female and less frequently were obese, were hypertensive, or had ischemic heart disease. Patients with RA and heart failure had fewer typical symptoms and signs and were less likely to undergo echocardiography compared with non-RA patients. After adjusting for differences, the patients with RA and heart failure were more likely to have preserved ejection fraction (>or=50%). Mortality at 1 year following heart failure was higher in patients with RA compared with non-RA patients (35% versus 19%; multivariable hazard ratio 1.89, 95% confidence interval 1.26-2.84).
CONCLUSION: Both the clinical presentation and the outcome of heart failure differ significantly between patients with and those without RA from the same population. Among patients with RA, the presentation of heart failure is more subtle, myocardial function is more likely preserved, while mortality from heart failure is significantly higher. These findings emphasize the importance of more vigilant screening of patients with RA for early signs of heart failure and may represent important insights into the biologic mechanisms underlying heart failure in RA.

Entities:  

Mesh:

Year:  2008        PMID: 18759286      PMCID: PMC2631416          DOI: 10.1002/art.23798

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  43 in total

Review 1.  Heart failure.

Authors:  Mariell Jessup; Susan Brozena
Journal:  N Engl J Med       Date:  2003-05-15       Impact factor: 91.245

2.  Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis.

Authors:  M Wisłowska; S Sypuła; I Kowalik
Journal:  Rheumatol Int       Date:  1999       Impact factor: 2.631

3.  Impaired diastolic function in active rheumatoid arthritis. Relationship with disease duration.

Authors:  C Montecucco; G Gobbi; S Perlini; S Rossi; A M Grandi; R Caporali; G Finardi
Journal:  Clin Exp Rheumatol       Date:  1999 Jul-Aug       Impact factor: 4.473

4.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

5.  Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease.

Authors:  M Wisłowska; S Sypuła; I Kowalik
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

6.  Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.

Authors:  Muhammad Mamdani; David N Juurlink; Douglas S Lee; Paula A Rochon; Alex Kopp; Gary Naglie; Peter C Austin; Andreas Laupacis; Therese A Stukel
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

7.  Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study.

Authors:  Funda Levendoglu; Ahmet Temizhan; Hatice Ugurlu; Ayse Ozdemir; Mehmet Yazici
Journal:  Rheumatol Int       Date:  2003-06-19       Impact factor: 2.631

8.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

Authors:  Michael R Zile; Catalin F Baicu; William H Gaasch
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

Review 9.  Left ventricular diastolic dysfunction and diastolic heart failure.

Authors:  William H Gaasch; Michael R Zile
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

10.  Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Am J Med       Date:  2004-03-01       Impact factor: 4.965

View more
  59 in total

Review 1.  Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality.

Authors:  Elena Myasoedova; John M Davis; Cynthia S Crowson; Sherine E Gabriel
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

2.  Preventing Heart Failure in Inflammatory and Immune Disorders.

Authors:  Maya Serhal; Chris T Longenecker
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-06

Review 3.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

4.  Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.

Authors:  Isabelle Amigues; Aylin Tugcu; Cesare Russo; Jon T Giles; Rachelle Morgenstein; Afshin Zartoshti; Christian Schulze; Raul Flores; Sabahat Bokhari; Joan M Bathon
Journal:  Arthritis Rheumatol       Date:  2019-02-28       Impact factor: 10.995

5.  Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.

Authors:  William Bradham; Michelle J Ormseth; Comfort Elumogo; Srikanth Palanisamy; Chia-Ying Liu; Mark A Lawson; Jonathan H Soslow; Nadine Kawel-Boehm; David A Bluemke; C Michael Stein
Journal:  J Rheumatol       Date:  2018-04-15       Impact factor: 4.666

6.  Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.

Authors:  Cynthia S Crowson; Elena Myasoedova; John M Davis; Veronique L Roger; Barry L Karon; Daniel Borgeson; Richard J Rodeheffer; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-05       Impact factor: 4.794

7.  Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population.

Authors:  Elena Myasoedova; John M Davis; Eric L Matteson; Sara J Achenbach; Soko Setoguchi; Shannon M Dunlay; Veronique L Roger; Sherine E Gabriel; Cynthia S Crowson
Journal:  Semin Arthritis Rheum       Date:  2019-07-15       Impact factor: 5.532

Review 8.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

9.  Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis.

Authors:  Panagiota Anyfanti; Eugenia Gkaliagkousi; Eleni Gavriilaki; Areti Triantafyllou; Panagiotis Dolgyras; Vasiliki Galanopoulou; Spyros Aslanidis; Stella Douma
Journal:  Clin Cardiol       Date:  2018-11-27       Impact factor: 2.882

Review 10.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.